Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma-Reference-Cited by-同舟云学术

Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma

Published:2021-10 Issue: Volume:221 Page:113529
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Castelli Riccardo,Taranto Sara^ORCID,Furiassi Lucia,Bozza Nicole,Marseglia Giuseppe,Ferlenghi Francesca,Rivara Silvia,Retini Michele,Bedini Annalida,Spadoni Gilberto,Matarazzo Sara,Ronca Roberto^ORCID,Presta Marco^ORCID,Mor Marco,Giacomini Arianna

Funder

Universita degli Studi di Brescia

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Fibroblast growth factors;Ornitz;Genome Biol.,2001

2. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease;Itoh;J. Biochem.,2011

3. Structural basis for fibroblast growth factor receptor activation;Mohammadi;Cytokine Growth Factor Rev.,2005

4. Blocking the FGF/FGFR system as a “two-compartment” antiangiogenic/antitumor approach in cancer therapy;Giacomini;Pharmacol. Res.,2016

5. The fibroblast growth factor signaling pathway;Ornitz;Wiley Interdiscip. Rev. Dev. Biol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel FGF trap small molecules endowed with anti-myeloma activity;Pharmacological Research;2024-08

2. GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain via the production of FGF2;Frontiers in Immunology;2023-02-08

3. Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications;Cytokine;2023-01

4. New developments in the biology of fibroblast growth factors;WIREs Mechanisms of Disease;2022-02-09